TITLE

V-myc in a simple, single gene retroviral vector causes rapid induction of leukemia and concomitant apoptosis following bone marrow transplantation

AUTHOR(S)
Dolnikov, A; Shounan, Y; Millington, M; Mackenzie, K; Symonds, G
PUB. DATE
April 1998
SOURCE
Leukemia (08876924);Apr98, Vol. 12 Issue 4, p542
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We have previously developed an in vivo model of leukemogen-esis utilizing mice reconstituted with genetically modified bone marrow cells. Based on those studies, a new single gene retro-viral vector has been engineered which efficiently transfers v-myc into immature murine bone marrow cells. All reconstituted mice developed leukemia with a short latency period (5-11 weeks). In addition to hyperproliferation associated with elevated levels of PCNA, extensive apoptosis was also observed in all leukemic animals with p53 accumulating in the apoptotic cells. Whereas bax encoded protein, an effector of p53 apop-totic activity was detected in apoptotic cells, p21[SUPWaf1] protein, a potential mediator of p53 growth suppression was not detected in these cells suggesting that v-myc-induced apoptosis was independent of the ability of p53 to induce p21[SUPWaf1]. These results indicate that apoptosis, a part of the cellular response to v-myc expression, does not prevent leukemia development and that hyperproliferation rather than abrogation of oncogene-induced apoptosis appears to be a critical event in v-myc-induced leukemia.
ACCESSION #
8882618

Tags: LEUKEMIA -- Etiology;  APOPTOSIS;  BONE marrow cells;  CANCER cells -- Proliferation

 

Related Articles

  • Bone marrow cells migrate to tumors and can slow their growth.  // Biomedical Market Newsletter; 

    The article focuses on the study which examines the role of bone marrow-derived cells (BMDCs) on tumor growth, which shows that more effective treatment for cancer can be developed through exploitation of BMDCs, with bone marrow cells migrate and slow the growth of tumors.

  • Tescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expression. Levay, Konstantin; Slepak, Vladlen Z. // Journal of Clinical Investigation;Sep2007, Vol. 117 Issue 9, p2672 

    We show here that the process of megakaryocytic differentiation requires the presence of the recently discovered protein tescalcin. Tescalcin is dramatically upregulated during the differentiation and maturation of primary megakaryocytes or upon PMA-induced differentiation of K562 cells. This...

  • Sex differences in the GSK3�-mediated survival of adherent leukemic progenitors. Bertrand, J; Despeaux, M; Joly, S; Bourogaa, E; Gallay, N; Demur, C; Bonnevialle, P; Louache, F; Maguer-Satta, V; Vergnolle, N; Payrastre, B; Racaud-Sultan, C // Oncogene;2/9/2012, Vol. 31 Issue 6, p694 

    Therapeutic resistance of acute myeloid leukemia stem cells, enriched in the CD34+38-123+ progenitor population, is supported by extrinsic factors such as the bone marrow niche. Here, we report that when adherent onto fibronectin or osteoblast components, CD34+38-123+ progenitors survive through...

  • Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. Skorski, Tomasz; Bellacosa, Alfonso; Nieborowska-Skorska, Margaret; Majewski, Miroslaw; Martinez, Robert; Choi, John K.; Trotta, Rossana; Wlodarski, Pawel; Perrotti, Danilo; Chan, Tung O.; Wasik, Mariusz A.; Tsichlis, Philip N.; Calabretta, Bruno // EMBO Journal;10/15/97, Vol. 16 Issue 20, p6151 

    The BCR/ABL oncogenic tyrosine kinase activates phosphatidylinositol 3-kinase (PI-3k) by a mechanism that requires binding of BCR/ABL to p85, the regulatory subunit of PI-3k, and an intact BCR/ABL SH2 domain. SH2 domain BCR/ABL mutants deficient in PI-3k activation failed to stimulate Akt...

  • FISH Adequate to Follow CML after Response. Artz, Andrew S. // Clinical Oncology Alert;Jan2010, Vol. 26 Issue 1, p1 

    Chronic myeloid leukemia (CML) is characterized by the Philadelphia chromosome (i.e., 9;22 translocation) created by the fusion of the ABL gene on chromosome 9 and the BCR gene on chromosome 22. As a consequence, activation of protein tyrosine kinase drives leukemogenesis and also enables...

  • Tripling Up On MiRNA Knocks Oncogenic Kinase Out Cold. Breindl, Anette // BioWorld Today;12/28/2007, Vol. 18 Issue 250, p1 

    The article focuses on a study which used a combination of microRNA to suppress the growth of leukemogenic bone marrow cells and prolong the lives of mice that were transplanted with bone marrow cells containing both the bcr-abl chimeric gene and miRNA combinations aimed at knocking it down....

  • Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells. Baskaran, D.; Spirin, P. V.; Prassolov, V. S. // Molecular Biology;Jun2010, Vol. 44 Issue 3, p369 

    Leukemias are a heterogeneous group of malignant blood diseases that are characterized by expansion of immature blast cells. The point molecular mechanisms of leukemogenesis are still unknown. Leukemia patients frequently have mutations of the genes responsible for normal proliferation and...

  • Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Inaba, Toshiya; Inukai, Takeshi // Nature;8/8/1996, Vol. 382 Issue 6591, p541 

    Looks at the mechanism by which the E2A-hepatic leukemia factor (HLF) fusion gene drives the leukaemic transformation of early B-cell precursors. Conclusion that the chimaeric oncoprotein probably affects cell survival rather than cell growth; Suggesting a model of leukaemogenesis in which...

  • Antitumor effect of Interferon-beta cDNA engineered human bone marrow mesenchymal stem cells to prostate cancer in vitro. Gongxian Wang; Yian Zhan; Yang Wang; HongLin Hu; Haiming Sang // Cell Research;Aug2008 Supplement, Vol. 18, pS65 

    Our purpose is to investigate the effect of human interferon-beta (huIFN-β) gene cDNA engineered human bone marrow mesenchymal stem cells (hMSCs) inhibit the growth of prostate cancer cell line PC-3 (PC-3) in vitro, and investigate a therapeutic strategy about the local production of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics